Recombinant insulin (Horizon Pharma/Ibatech)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant insulin (Horizon Pharma/Ibatech)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonistsInsulin ligand
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsDiabetes Mellitus, Type 1
Approved Indications in ChinaN/A
Original Approved Country/TerritoryPoland
Original Approved Date2002/07/01
Country/TerritoryPoland
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSavient Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeA10AB01A10AC01A10AD01 +[5] 
Related LinksN/A